The management of patients with central nervous system germ-cell tumours is evolving, and a definitive standard has not been achieved. A large amount of data indicate that
radiotherapy alone results in long-term relapse free survival rates of about 90% in patients with
germinoma. Various prospective trials evaluated the results of combinations of
chemotherapy and reduced dose and/or volume
radiotherapy. The survival rates of combined treatment approaches were similar to the rates achieved with craniospinal
radiotherapy alone. Nevertheless, the relapse rates were probably higher due to the significant number of relapses that arouse outside the volume treated with
radiotherapy. Additional studies are necessary to determine the appropriate
radiotherapy volumes and the role of combined treatments.
Chemotherapy alone results in high relapse rates and can not be recommended. Mature
teratomas are benign germ cell tumours that can be controlled with complete surgical resection in over 90% of cases. Non-
germinoma germ cell tumours are a heterogeneous group of tumours that includes very aggressive tumours such as mixed and pure
choriocarcinomas, yolk sac tumours, and
embryonal carcinomas; and tumours with intermediate aggressiveness such as mixed tumours with
germinoma and
teratoma, immature teratomas and
teratomas with malignant transformation. Both
radiotherapy alone and
chemotherapy alone result in quite low rates of tumour control and current treatment approaches include
chemotherapy and
radiotherapy, with surgical removal of the tumour in some patients.
Pineocytomas are benign tumours that are controlled in most cases by complete surgical resection or partial surgical resection and local field irradiation. Current treatment approaches for
pineoblastomas include surgery,
chemotherapy, and
craniospinal irradiation with a local boost.
Chemotherapy alone was used to delay irradiation in infants with very little success.